풀몬엑스 (LUNG) 주가

풀몬엑스(LUNG)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $2.42 (+12.04%), 시가총액 $0.05B, 52주 범위 $1.17 ~ $3.78.

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is

핵심 지표

• 현재가: $2.42 (+12.04%)
• 시가총액: $0.05B
• 52주 최저~최고: $1.17 ~ $3.78
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

풀몬엑스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

풀몬엑스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.2857

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.16
• 순이익률: -0.60%
• 영업이익률: -0.63%

자주 묻는 질문